Purchase Order 75N92024P00305
Award Date
10/6/24
Potential Completion Date
4/5/26
Potential Value
$229K
Federal Agency
National Heart Lung and Blood Institute
Awardee
Illumina, Inc.
Ultimate Awardee
Not listed
NAICS Category
334516 - Analytical Laboratory Instrument Manufacturing
PSC Category
6640 - Laboratory Equipment And Supplies
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
White Plains, NY 10601, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed price purchase order contract awarded by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Illumina, Inc. The contract has a ceiling value of $646,396.36 and no set-aside designation. Illumina, a manufacturer of sequencing and array-based genomic analysis solutions, will provide a range of sequencing systems, reagents, and services to support NHLBI's research and diagnostics needs. Illumina has a history of...
This is a firm fixed price purchase order contract awarded by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Illumina, Inc. for the provision of sequencing services. The contract has a ceiling value of $95,569.54 and does not include any set-aside provisions. Illumina, a manufacturer of genetic analysis instruments and reagents, has previously received prime federal contracts and grants from agencies including the NIH, Centers...
This is a firm fixed-price purchase order contract awarded by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Illumina, Inc. The objective is to procure a comprehensive maintenance plan that includes parts, labor, and materials for an Illumina HiSeq 2500 DNA sequencing instrument. The contract has a ceiling value of $442,123.75 and a period of performance through December 22, 2020. Illumina is a manufacturer of genomic sequencing...
This is a firm fixed price purchase order contract awarded by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Illumina, Inc. The contract has a ceiling value of $81,254.25 and a period of performance ending on August 18, 2017. It does not have a set-aside designation. The contract provides for Illumina to deliver a range of genomic sequencing systems, reagents, consumables, and support services to the NHLBI. This includes Illumina's...
This firm fixed-price purchase order was awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Heart Lung and Blood Institute to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents. The $184,285.77 contract is for maintenance services on the government-owned Illumina NovaSeq 6000 genetic sequencing equipment, to ensure it operates safely and with minimal downtime. The original solicitation called for the contractor...
This is a firm fixed-price delivery order contract awarded by the National Heart Lung and Blood Institute (NHLBI), which is part of the National Institutes of Health (NIH), to Illumina, Inc. The contract is valued at $147,915.00 and has an ultimate completion date of April 5, 2026. The purpose of the contract is to provide a service contract with Illumina in order to protect the NHLBI DNA sequencing machines and provide service for NHLBI principal investigators, fellows, and staff. The...
This firm fixed-price purchase order contract, awarded by the National Heart Lung and Blood Institute (NHLBI) of the National Institutes of Health (NIH), provides Illumina, Inc. with a NovaSeq X Plus sequencing system to support genomic research initiatives. The $999,999.00 contract has a completion date of September 19, 2024. Illumina is a leading manufacturer of genetic sequencing and analysis technologies, and has been awarded numerous federal contracts and grants to supply sequencing...
This is a firm fixed price delivery order awarded by the National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health (NIH), to Illumina, Inc. The order is for Illumina sequencing kits and reagents to support next-generation sequencing on Illumina instruments for NHLBI's Sequencing Core Facility. The total ceiling value of the order is $21,236.13, with a period of performance through June 8, 2025. No set-aside was used for this award. Illumina is a manufacturer of...
This $28,709.96 firm fixed price delivery order was awarded by the National Heart, Lung, and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Illumina, Inc. for the maintenance and support of a NextSeq sequencing instrument to enable DNA sequencing and genomics research for NHLBI principal investigators, fellows, and staff. The award has no set-aside designation. Illumina, a manufacturer of sequencing and genomic analysis instruments and reagents, has...
This is a firm fixed price delivery order awarded by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Illumina, Inc. The contract is for the provision of laboratory equipment and supplies, specifically Illumina's genetic sequencing systems and related consumables. The contract has a total ceiling value of $84,812.59 and a period of performance through September 2, 2020. There is no set-aside designation for this award. Illumina has...